{"id":"https://openalex.org/W2189092964","doi":"https://doi.org/10.1016/j.jval.2015.09.550","title":"Intravitrael Aflibercept Injection for The Treatment of Visual Impairment Due to Macular Oedema Secondary to Branch Retinal Vein Occlusion: Cost-Effectiveness Versus Ranibizumab","display_name":"Intravitrael Aflibercept Injection for The Treatment of Visual Impairment Due to Macular Oedema Secondary to Branch Retinal Vein Occlusion: Cost-Effectiveness Versus Ranibizumab","publication_year":2015,"publication_date":"2015-10-20","ids":{"openalex":"https://openalex.org/W2189092964","doi":"https://doi.org/10.1016/j.jval.2015.09.550","mag":"2189092964"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2015.09.550","doi":"https://doi.org/10.1016/j.jval.2015.09.550","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2015.09.550","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jval.2015.09.550","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"E Lovato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E Lovato","raw_affiliation_strings":["IMS Health, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Health, London, UK","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040719420","display_name":"Adam Lloyd","orcid":"https://orcid.org/0000-0001-6890-2121","observed_orcids":["https://orcid.org/0000-0001-6890-2121"]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Lloyd","raw_affiliation_strings":["IMS Health, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Health, London, UK","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":null,"display_name":"B Wilson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166605","display_name":"Bayer (United Kingdom)","ror":"https://ror.org/05emrqw14","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210166605","https://openalex.org/I67348948"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B Wilson","raw_affiliation_strings":["Bayer HealthCare, Newbury, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Newbury, UK","institution_ids":["https://openalex.org/I4210166605"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037778922","display_name":"KU Wittrup-Jensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KU Wittrup-Jensen","raw_affiliation_strings":["Bayer Pharma AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma AG, Berlin, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.3231,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.65859693,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"18","issue":"7","first_page":"A419","last_page":"A419"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.8871999979019165,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.8871999979019165,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.09650000184774399,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11438","display_name":"Retinal Imaging and Analysis","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":0.9430000185966492},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":1.0},{"id":"https://openalex.org/keywords/macular-edema","display_name":"macular edema","score":0.8349999785423279},{"id":"https://openalex.org/keywords/branch-retinal-vein-occlusion","display_name":"branch retinal vein occlusion","score":1.0},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.8790000081062317},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9629999995231628},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.8410000205039978},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9010000228881836},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.7080000042915344},{"id":"https://openalex.org/keywords/patient-access-schemes","display_name":"patient access schemes","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.9427284002304077},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8852496147155762},{"id":"https://openalex.org/C2780261187","wikidata":"https://www.wikidata.org/wiki/Q4956400","display_name":"Branch retinal vein occlusion","level":4,"score":0.759967565536499},{"id":"https://openalex.org/C2778749236","wikidata":"https://www.wikidata.org/wiki/Q4689286","display_name":"Aflibercept","level":4,"score":0.7259422540664673},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.6808282136917114},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5016157627105713},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.41185683012008667},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.37643975019454956},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3118329644203186},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.2168911099433899},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.19203323125839233},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2015.09.550","doi":"https://doi.org/10.1016/j.jval.2015.09.550","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2015.09.550","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2015.09.550","doi":"https://doi.org/10.1016/j.jval.2015.09.550","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2015.09.550","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2228229668","https://openalex.org/W2540997876","https://openalex.org/W7208003494","https://openalex.org/W4281812343","https://openalex.org/W1964541004","https://openalex.org/W854733611","https://openalex.org/W2779687202","https://openalex.org/W2315585922","https://openalex.org/W2895325483","https://openalex.org/W3133810367"],"abstract_inverted_index":null,"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}